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Purple sweet potato color (PSPC), a naturally occurring anthocyanin, has a powerful antioxidant activity in vitro and in vivo.
This study explores whether PSPC has the neuroprotective eﬀect on the aging mouse brain induced by D-galactose (D-gal).
The mice administrated with PSPC (100mg/kg·day, 4 weeks, from 9th week) via oral gavage showed signiﬁcantly improved
behavior performance in the open ﬁeld and passive avoidance test compared with D-gal-treated mice (500mg/kg·day, 8 weeks).
We further investigate the mechanism involved in neuroprotective eﬀects of PSPC on mouse brain. Interestingly, we found, PSPC
decreased theexpression level of glial ﬁbrillaryacidic protein (GFAP),inducible nitricoxide synthase(iNOS), and cyclooxygenase-
2 (COX-2), inhibited nuclear translocation of nuclear factor-kappaB (NF-κB), increased the activity of copper/zinc superoxide
dismutase (Cu/Zn-SOD) and catalase (CAT), and reduced the content of malondialdehyde (MDA), respectively. Our data
suggested that PSPC attenuated D-gal-induced cognitive impairment partly via enhancing the antioxidant and anti-inﬂammatory
capacity.
Copyright © 2009 Qun Shan et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
There is considerable evidence that oxidative stress plays an
important role during the pathogenesis of age-associated or
neurodegenerative disease [1]. Oxidative stress is caused by
the imbalance between the reactive oxygen species (ROS)
production and ROS elimination in the biological system.
And it leads to oxidative damage to cell and tissue paralleled
by modiﬁcations in the morphology and function, resulting
in aging and premature cell death. The aging animal is
easily subjected to the alteration of observed behavior such
as the reduction of spontaneous behavior, the decline of
learning, and memory function. Now a decline in memory
and cognitive function is considered to be a consequence
of aging and age-related neurodegenerative disorders [2, 3].
The age-related impairment in learning and memory may be
relieved by antioxidant treatment [4].
One approach to protect against ROS in aging and
neurodegenerative disorders is to enhance biological defense
activities via antioxidants. Recently, most eﬀorts to prevent
and treat neurodegenerative disorders focus on dietary
antioxidant components, including vitamins and phenolic
compounds [5]. Anthocyanins are a class of naturally
polyphenolic compounds that give the intense color to
many ﬂowers and fruits in the high plants. They have
been reported to show several eﬀectively pharmacological
properties such as anti-inﬂammation, antioxidation [6, 7],
and antimutagen [8, 9]. Purple sweet potato (Ipomoea
batatas) has been regarded as an abundant source of
stable anthocyanins [10] and has been attracted extensive
attentions. The previous studies on purple sweet potato
color (PSPC) have focused on its stability, structure, and
physiological functionality and functional food exploita-
tion [11–13]. However, it is still uncertain whether PSPC2 Journal of Biomedicine and Biotechnology
could improve spontaneous behavior, learning, and memory
function, and whether PSPC could have a neuroprotective
eﬀect on brain damage induced by the oxidation and
inﬂammation.
D-galactose (D-gal) is a naturally occurring chemical
substance in the body; however, at high levels, it can cause
the accumulation of ROS, ﬁnally resulting in oxidative
stress. Recently, D-gal was used to inject mice or rats
for pharmacological studies. Evidence has shown that D-
gal caused aging-related changes including the increase of
ROS and the decrease of antioxidant enzyme activity [14,
15]. D-gal could simultaneously cause the behavioral and
neurochemical changes [15–18]. The D-gal-injected mouse
has been utilized to be a model for antiaging pharmacology
and brain aging studies.
In this study, we investigated the neuroprotective eﬀect
of PSPC on impaired explortary behavior, learning, and
memory in the D-gal-treated mouse and the underlying
neuroprotective mechanism of PSPC on mouse brain.
2.MaterialandMethods
2.1. Animals and Administration. Male Kunming mice
(30.23 ± 5.12g body weight) were purchased from the
Branch of National Breeder Center of Rodents (Shanghai,
China). They were housed in a ventilated, temperature-
controlled (23 ± 1◦C), and standardized sterile animal
room. Eight mice were housed per cage and had free
access to food and water under 12hours light/dark schedule
(lights on from 08:30 to 20:30 hour). After acclimatization
to the laboratory for one week, group 1 and group 3
were injected (s.c.) with D-gal at dose of 500mg/(kg.day)
(Sigma-Aldrich, MO, USA) [19], and group 2 and group
4 were injected with 0.9% saline for 8 weeks. Then group
1 and group 4 were administrated by oral gavage with
PSPC(Ipomoeabatatas;TsingtaoPengyuanNaturalPigment
Research Institute, China; the major components of PSPC
by HPLC analysis are cyanidin acyl glucosides and peonidin
acyl glucosides (> 90%), and the others are other ﬂavonoids)
in distilled water containing 0.1% Tween 80 at dose of
100mg/(kg.d); at the same time other two groups received
distilled water containing 0.1% Tween 80 without PSPC
for another four weeks. Before experiment, the mean body
weightsofeachgroupwereexamined:controlgroup:30.08±
3.15g; D-gal group: 31.13 ± 4.22g; D-gal + PSPC group:
29.82 ± 4.71g; PSPC group: 30.16 ± 2.27g. After 12-week
administration, the mean body weights of each group
were also examined: control group: 38.28 ± 2.14g; D-gal
group: 39.13 ± 1.66g; D-gal + PSPC group: 39.82 ± 2.59g;
PSPC group: 38.03 ± 2.33g. The administration of D-gal
and/or PSPC does not signiﬁcantly inﬂuence on the body
weight change and the feeding in the mice. The procedures
used in the experiment were conducted according to the
regulations of the ethics committee of the International
Association on the use and care of laboratory animals and
were approved by the respective university committees for
animal experiments.
2.2. Behavioral Tests
2.2.1. Open-Field Testing. The open ﬁeld has proven useful
for evaluation of the eﬀects of drugs on behavior. Locomotor
activity and exploratory behavior were examined using a
circular arena measuring 50cm in diameter and 30cm in
height with a 40W bulb (3000lux). The ﬂoor of the arena
was equally divided into 21 units by white lines. Tests were
carriedoutintheanimalroomfrom8:30to16:00asreported
previously [20]. Each mouse was placed at the center of the
arena. The spontaneous behavioral variables were classiﬁed
into 4 mutuallyexclusive categories, including the number of
timesofrearing,leaning,grooming,andambulationrecoded
for 5minutes.
2.2.2. Passive-Avoidance Testing. The apparatus consisted of
an illuminated compartment (11.5cm × 9.5cm × 11cm)
and a dark compartment (23.5cm× 9.5cm × 11cm). The
two compartments were separated by a sliding door, and the
dark one contained a metal ﬂoor that could deliver foot-
shocks. The illuminated compartment was lit with a 25W
lamp. The passive avoidance test was performed as described
previously [21]. The mouse was ﬁrstly placed in the dimly lit
room to acclimate the new environment with the apparatus
for 0.5 hour before entering the dark compartment. Latency
was deﬁned as the interval between the initial opening of
the door and the fully entry of the mouse to the dark
compartment. The mouse was individually placed in the
illuminated compartment facing away from the door. Once
themouseescapedtotheilluminatedcompartment,thedoor
was closed and a mild footshock (0.3mA, 50Hz, 5seconds)
was triggered. Immediately the mouse was removed from the
apparatus. To carry out the retention trial, the mouse was
placed once again in the illuminated compartment 72 hours
later. The retention trial followed the method mentioned
above in the footshock. The latency (avoidance latency) was
recorded. The retention session lasted a maximum (“cut-
oﬀ”) of 300 seconds. The test was conducted in 2 days
immediately following the open-ﬁeld testing.
2.3. Tissue Homogenarate. For biochemical analysis, ani-
mals were deeply anesthetized and sacriﬁced. Brains were
promptlydissectedandperfusedwith50mMcoldphosphate
buﬀer saline solution (PBS, pH7.4). Brains were homoge-
nized in 1/5 (w/v) PBS containing Complete Mini Protease
Inhibitor Cocktail tablets (Roche Diagnostics Corporation,
Indianapolis, IN, USA) with 10 strokes at 1200rpm in a
Potter homogenizer. Homogenates were divided into two
portions. One part was directly centrifuged at 8000xg for
10minutes at 4◦C, and the supernatants were collected to
measure MDA content. The other part was sonicated four
times for 30seconds with 20seconds intervals using a VWR
Branson Scientiﬁc ultrasonicator (VWR Int. Ltd, Merch
House Pool, UK). The homogenates were centrifuged at
5000xg for 10minutes at 4◦C to obtain the supernatants for
determination of Cu/Zn-SOD and CAT activities.
For western blot analysis, the brain tissues were dis-
sected and homogenized in 1/3 (w/v) Tris-buﬀered saline
(TBS) containing Complete Mini Protease Inhibitor CocktailJournal of Biomedicine and Biotechnology 3
tablets with 10 strokes at 1200rpm in a Potter homogenizer.
The homogenates were centrifuged at 10000xg for 10
minutes at 4◦C. And the supernatants were collected and
stored at −70
◦C for the measurement of GFAP, COX-2, and
iNOS.Nuclearandcytoplasmicproteinswereextractedusing
an NE-PER kit (Pierce Biotechnology, Inc., Rockford, USA).
Nuclear proteins and cytoplasmic proteins were performed
by western blot analysis of NF-κB nuclear translocation.
Protein content was determined by using the BCA assay
(Pierce Biotechnology, Inc., Rockford, USA).
2.4. Assay of Cu/Zn-SOD and CAT Activity. Cu/Zn-SOD and
CAT activities were measured using chemicals purchased
from Sigma Chemical Company (USA). Cu/Zn-SOD activity
was spectrophotometrically monitored at 550nm according
to the method described by Sun et al. [22]. SOD activity
was showed as U/mg protein with reference to the activity
of a standard curve of bovine Cu/Zn-SOD under the same
condition.
CAT activity was measured on the basis of Aebi [23].
Brieﬂy, 50μL sample and 0.65mLof 50mM PBS (PH7.0)
were added to a quarts cuvette, and 0.3mLof 30mM
hydrogen peroxide was used as the substrate. The light
absorbance at 240nm (25
◦C) was determined. Enzymatic
a c t i v i t yw a se x p r e s s e da sn MH 2O2 decomposed/min/mg
protein.
2.5. Measurement of MDA Level. MDA content was mea-
sured using chemicals purchased from Sigma Chemical
Company (USA). The level of MDA in brain tissue
homogenates was assessed as an index of lipid peroxidation
by the method of Mihara and Uchiyama [24]. 500μL
homogenate was mixed with 3mLof H3PO4 solution (1%,
v/v) followed by addition of 1mLof thiobarbituric acid
solution (0.67%, w/v). Then the mixture was heated in a
water bath (95
◦C) for 45 minutes. The colored complex
was extracted into n-butanol and cooled to the room
temperature. The absorption at 532nm was measured using
tetramethoxypropane as standard. MDA level was expressed
as nmol per mg of protein.
2.6. Western Blot Analysis of GFAP, COX-2, iNOS, and NF-
κB. Sample buﬀer (0.1M Tris-HCl, 20% glycerol, 4% SDS,
and 0.01% bromophenol blue) was added to aliquot of the
supernatant fraction from the lysates. Samples were boiled
for 5 minutes. Aliquots of 80μg protein were subjected to
10% SDS-PAGE. The separated proteins were transferred
to PVDF membrane (Roche Diagnostics Corporation, Indi-
anapolis, IN, USA) for 1 hour at 350mA. The membrane
was preblocked with 5% nonfat milk or 5% w/v BSA in TBS
containing 0.1% Tween 20, incubated with the primary anti-
body at 4◦C with gentle shaking, overnight. Each membrane
was washed 3 times for 5 minutes and incubated with the
secondary horseradish peroxidase-linked antibody (Santa
Cruz Biotechnology, CA and Cell Signaling Technology,
Beverly, MA, resp.). Quantitation of detected bands was
performed with the Scion Image analysis software (Scion
Corp., Frederick, MD, USA). Each density was normalized
by corresponding β-actin (40μgs a m p l e )o rβ-tubulin (40μg
sample) as an internal control. We standardized the density
of control group for relative comparison as 1.0 to compare
other group.
2.7. Statistical Analysis. All statistical tests were performed
with the statistical program SPSS 11.5. One-way analysis
of variance (ANOVA) was applied with Newman-keuls or
Tukey’s HSD posthoc comparisons. The data were expressed
as means ± SEM. Statistical signiﬁcance was set at P<. 05.
3. Results
3.1. Eﬀe c to fP S P Co nt h eB e h a v i o ro fD - G a l - T r e a t e dM o u s e
3.1.1. Open-Field. Open-ﬁeld behaviors were observed to
identify the behavioral diﬀerence in response to a novel
environment. The behaviors included exploratory, adaptive,
and locomotor abilities of animals expressed by line cross-
ing, rearing/leaning and grooming. The data presented in
Figure 1 indicated that, in comparison to the control group
withinjectionofsaline(0.9%),thebehavioractivitiesofmice
group subcutaneously injected by using D-gal (D-gal model)
cut down on the activities of line crossing (F(3,28) = 6.210,
P<. 01), rearing/leaning (F(3,28) = 6.292, P<. 01), and
grooming (F(3,28) = 7.484, P<. 001). This result showed
that the impairment of the exploration activities appeared in
the mice treated with D-gal. When D-gal-induced mice were
received 100mg/(kg.d) of PSPC, their activities of crossing
(P<. 001), rearing/leaning (P<. 001), and grooming (P<
.001) were signiﬁcantly increased. However, there was no
statistically signiﬁcant between the control group and the
study group only received PSPC.
3.1.2. Passive-Avoidance Testing. In the initial trial, the
passive-avoidance latency showed no diﬀerence among the
four groups (F(3,28) = 0.622, P>. 05) (See Figure 2).
However, the latency in the 72 hours retention trial was
signiﬁcantly decreased (F(3,28) = 6.476, P<. 01) in the D-
gal-treated mice, as compared with the control. In contrast
to the D-gal model, the latency of the D-gal-treated mice
fed with 100mg/(kg.d) PSPC for 4 weeks was signiﬁcantly
increased (P<. 05). However, no signiﬁcant diﬀerence was
found between the study group only treated with PSPC and
the control group.
3.2. Eﬀect of PSPC on the Cu/Zn-SOD and CAT Activity.
Cu/Zn-SOD and CAT are two kinds of important enzymes
in the antioxidant defense system. Cu/Zn-SOD can catalyze
the conversion of O
−
2 into H2O2; furthermore, CAT converts
H2O2 to H2O and O2. To determine whether PSPC could
ameliorate oxidative damage in the brain of D-gal-treated
mouse, we measured the activities of antioxidant enzymes
Cu/Zn-SOD and CAT. Figure 3 showed the activities of
Cu/Zn-SOD and CAT in mouse brain. We found from the
two ﬁgures, compared with control, that D-gal treatment
signiﬁcantly decreased Cu/Zn-SOD (P<. 001, Figure 3(a))
and CAT (P<. 05, Figure 3(b)) activities, while PSPC could
reverse the above changes to the normal level. And there was4 Journal of Biomedicine and Biotechnology
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Figure 1: Eﬀects of PSPC on open-ﬁeld behaviors of mice as
measured by (a) the number of grid crossing, (b) rearing and
leaning,and(c)grooming.Allvaluesareexpressedasmeans ±SEM
(n = 8). ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001 versus D-gal model. Scale
bars: 100μM.
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Figure 2: Performance in the passive avoidance test. All values are
expressed as means ± SEM (n = 8). ∗P<. 05, ∗∗ P<. 01, ∗∗∗ P<
.001 versus D-gal model. Scale bars: 100μM.
no signiﬁcant diﬀe r e n c eb e t w e e nP S P Cg r o u pa n dc o n t r o l
group.
3.3. Eﬀe c to fP S P Co nt h eM D AC o n t e n t .M D Ai sah i g h l y
reactive three carbon dialdehyde produced as a byproduct of
polyunsaturatedfattyacidperoxidationandarachidonicacid
metabolism and readily combines with several functional
groups on molecules including proteins, lipoproteins, and
DNA. Therefore, MDA is often measured as a major marker
of lipid peroxidation in the aging tissue [25]. As shown
in Figure 4, MDA level in D-gal-treated group was higher
than that in the control group (P<. 001). PSPC depressed
MDA enhancement in mouse brain (D-gal/PSPC versus D-
gal model, P<. 01). While compared with control group,
both D-gal/PSPC group and PSPC group did not show
signiﬁcant change.
3.4. Eﬀect of PSPC on the Expression of iNOS, COX-2,
and Nuclear Translocation of NF-κB. Am a r k e ro fC N S
inﬂammation is the activation of microglia that produces
neurotoxic factor nitric oxide (NO). Generally, the inducible
NOS could generate NO, which played an important role
in inﬂammatory response [26]. Our Western blot analysis
revealed that D-gal upregulated the expression of iNOS
protein (P<. 01 versus control group), and its level was sig-
niﬁcantly decreased after PSPC administration. Compared
with control group, there was no signiﬁcant diﬀerence in D-
gal/PSPC group and PSPC group (Figure 5(a)).
COX-2 is a rate-limiting enzyme in converting arachi-
donic acid to prostaglandins. The increasing introduction
of prostaglandins in the body can lead to the inﬂammatory
response. We found from Figure 5(b) that D-gal-treatment
caused an increase in COX-2 expression in mouse brain (P<
.001 versus control). When D-gal-treated mice were fed with
PSPC, COX-2 level dramatically declined (P<. 001 versus
D-gal model), while PSPC treatment alone did not aﬀect the
basal COX-2 expression.
COX-2 promoter contains the binding site for transcrip-
tion factor of NF-κB[ 27]. NF-κB translocation means itsJournal of Biomedicine and Biotechnology 5
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Figure 3: Pharmacological column for the eﬀect of PSPC on the
activity of Cu/Zn-SOD (a) and CAT (b). Each value is the means
± SEM (n = 5). ∗P<. 05, ∗∗ P<. 001, ∗∗∗ P<. 001 versus D-gal
model.
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content. Each value is the means ± SEM (n = 5). ∗P<. 05, ∗∗ P<
.01, ∗∗∗ P<. 001 versus D-gal model.
activation from the cytosol to the nucleus. At the same
time we investigated NF-κB level in the nucleus. The results
showed that PSPC markedly attenuated the activity of NF-
κB induced by D-gal (D-gal/PSPC versus D-gal model, P<
.01, Figure 5(c)). However, there is no statistical variation
between PSPC group and control group.
3.5. Eﬀect of PSPC on the Expression of GFAP Protein. GFAP
was an intermediate ﬁlament that mediates the extension
of astrocyte processes, and it has been considered as a
reliable marker to document age-related increase in brain
of rodents and humans subjects [28–31]. We measured the
GFAP expression in mouse brain. As shown in Figure 6,
there was a sharp contrast to control group in D-gal-treated
group, where twofold amount of GFAP was detected (P<
.01). Compared with control group, there was no signiﬁcant
variation in D-gal/PSPC group and PSPC group. Thus, the
supplement of PSPC appears to attenuate the production of
GFAP protein induced by D-gal.
4. Discussion
Aging represents a fundamental biological phenomenon; it
can be considered as an inevitable progressive process related
to the accumulation of oxidative damage. During normal
aging, the brain undergoes morphologic and functional
changes resulting in the observed behavioral retrogression
such as declines in motor and cognitive performance. These
declines are augmented by neurodegenerative diseases
including amyotrophic lateral sclerosis (ALS), Alzheimer’s
disease (AD), and Parkinson’s disease (PD) [32]. Currently
it has been an encouraging challenge for genetic biology
to discover an eﬀective therapy for aging. Therapies in
aging may be aimed at reversing or decelerating age-related
modiﬁcations once they have occurred at various points
in the life span [33]. D-gal is a reducing sugar and can be
metabolized at normal concentration. However, at high
levels, it can be converted into aldose and hydroperoxide
under the catalysis of galactose oxidase, resulting in the
generation of a superoxide anion and oxygen-derived
free radicals [10]. D-gal also reacted readily with the
free amines of amino acids in proteins and peptides in
vivo to form advanced glycation endproducts (AGEs)
[10]. Evidence showed that AGEs could remarkably
cause the accumulation of ROS and also trigger neuronal
inﬂammatory through activation of NF-κBp a t h w a y ,w h i c h
induced the behavioral impairment of learning and memory
and decreased antioxidant enzyme activities in the brain.
By this token, ROS, AGEs, and inﬂammatory response
induced by D-gal contributed to the neurotoxic eﬀect
[10, 15, 20, 34]. These changes are considerably similar
to the normal aging process. So the mouse treated with
D-gal has been served as the aging model and has been
utilized to investigate the mechanism related to the aging.
Flavonoids are unique phytochemicals and have powerful
antioxidants. They appear potential in antiaging and anti-
inﬂammation properties [35, 36]. Purple sweet potato color
is one of the major ﬂavonoids and has displayed some
physiological eﬀects and food exploitation. In this study,6 Journal of Biomedicine and Biotechnology
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Figure 5: Western blot analysis of the expression level of representative protein in mouse brain (n = 3). (a) iNOS, (b) COX-2, (c) NF-κB:
cytoplasmic(C)proteinswereisolatedandusedforwesternblotanalysis,(d)NF-κB:Nuclear(N)proteinswereisolatedandusedforwestern
blot analysis. Data are averages from three independent experiments. Each value is the means ± SEM ∗P<. 05, ∗∗ P<. 01, ∗∗∗ P<. 001
versus D-gal model.
PSPC is mostly composed of cyanidin acyl glucosides and
peonidin acyl glucosides (peonidin 3-O-(6-O-(E)-caﬀeoyl-
2-O-β-D-glucopyranosyl-β-D-glucopyranoside)-5-O-β-D-
glucoside, peonidin 3-O-(2-O-(6-O-(E)-caﬀeoyl-β-D-glu
copyranosyl)-6-O-(E)-caffeoyl-β-D-glucopyranoside)-5-
O-β-D-glucopyranoside, peonidin 3-O-(2-O-(6-O-(E)-
feruloyl-β-D-glucopyranosyl)-6-O-(E)-caﬀeoyl-β-D-gluco
pyranoside)-5-O-β-Dglucopyranoside, cyanidin3-O-(6-O-
p-coumaroyl)-β-D-glucopyranoside)byHPLCanalysis[37].
Evidence showed that cyanidin acyl glucosides and peo-
nidin acyl glucosides had higher antioxidant and anti-
inﬂammatory capacity [38]. The acylated cyanidin and
peonidin as the major components of PSPC played an
important role in pharmacological eﬀect of PSPC. Our
results also demonstrated that the PSPC is an eﬀective
antioxidant and anti-inﬂammatory agent. It could alleviate
or reverse the D-gal-caused neurotoxicity by regulating the
R O Sl e v e l si nm o u s eb r a i n .Journal of Biomedicine and Biotechnology 7
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Figure 6: Western blot analysis of the expression level of GFAP
p r o t e i ni nm o u s eb r a i n( n = 3). Data are averages from three
independent experiments. Each value is the means ± SEM ∗P<
.05, ∗∗ P<. 01, ∗∗∗ P<. 001 versus D-gal model.
In our behavioral tests, we found that D-gal could
remarkably lead to the impairment of learning and memory
inmice.However,bothopen-ﬁeldandpassiveavoidancetask
suggested that there appeared a novel eﬀe c to fP S P Co nt h e
improvement of brain functions during aging. On one hand,
PSPC signiﬁcantly inhibited the behavioral retrogression,
such as rearing/leaning, grooming, and crossing, induced by
D-gal. PSPC could also reverse the impairment of learning
and memory in D-gal-treated mice.
To further identify the molecular mechanism associated
with the recovery capability of the aging brain by PSPC
treatment following D-gal-induced injury, we utilized the
western blot analysis and biochemistry evaluation to study
the relative expression of representative protein or enzyme
or metabolic product-associated aging in mouse brain. Brain
aging is accompanied by behavioral deﬁcits, including cog-
nitive and motor performances. These deﬁcits are probably
induced by oxidative damage and inﬂammation [32, 39].
The excessive ROS produced would speed up the breakdown
of biomacromolecules. thus the body could be subjected
to the oxidative damage. However antioxidant enzymes can
greatlyattenuateoxidativedamage,providingsupportforthe
free radical theory of aging [40]. D-gal could remarkably
cause the decrease of antioxidant enzyme activity such as
Cu/Zn-SOD and CAT (Figure 3) and the accumulation of
ROS, whereas PSPC could restore the activity of Cu/Zn-SOD
and CAT and signiﬁcantly enhanced the antioxidant capacity
of the body. The increased MDA content is an important
indicator of oxidative damage in brain [40]. We also found
that PSPC decreased the generation of MDA induced by D-
galand reduced the production of the free radical. Therefore,
PSPC retarded the aging rate induced by D-gal through the
alleviation of oxidative damage.
Oxidative damage is one of the main factors of brain
aging. The studies also suggest that brain aging is associ-
ated with the neuroinﬂammation. Evidence indicated that
oxidative stress and AGEs induced by D-gal both caused
neuroinﬂammation [41, 42]. Neuroinﬂammation had been
connected to the activation of inﬂammatory factors iNOS
and COX-2, the upregulation of GFAP expression, and
the promotion of nuclear translocation of NF-κB[ 43–
47]. Figures 5(a)–5(c) and Figure 6 indicated that D-gal-
treatment caused inﬂammatory response, in which iNOS,
COX-2, and GFAP levels were increased, and NF-κBa c t i v i t y
was also upregulated. It was remarkable that PSPC could
reverse the injurious eﬀect of D-gal. This kind of inhibitory
function from PSPC is likely to be due to the impactful
eﬀect of the anthocyanins on the inﬂammation. Pergola et al.
found that cyanidin from the blackberry extract eﬀectively
brought down the expression of iNOS protein induced by
proinﬂammatory stimuli bacterial lipopolysaccharide (LPS)
[48]. The other report revealed that cyanidin inhibited the
expression of COX-2 and NF-κB induced by LPS as well [6].
Our results indicated that PSPC not only downregulated the
expression of COX-2 and iNOS protein but also inhibited
nuclear translocation of NF-κB which was associated with
the decreased AGEs levels (data not shown). So PSPC signif-
icantly attenuated the progressive inﬂammation induced by
D-gal in mouse brain. Actually, NF-κB was a transcriptional
regulator that could control the expression of iNOS gene
and COX-2 gene in modulating inﬂammation and oxidative
stress associated with brain aging [49, 50]. NF-κB signaling
system is one of the main stress signaling pathways and/or
central mediator in response to oxidant damage [47]. The
results suggested that PSPC showed anti-inﬂammatory eﬀect
in the neurotoxin pathway due to its strongly modulating the
COX-2 and iNOS expression by reducing NF-κB activation.
And PSPC ameliorated D-gal-induced brain impairment
partly by inhibiting NF-κB signaling pathway.
Our group previously found that the impairment of
memory and the loss of synaptic protein associated with
memory formation in D-gal-treated mice may be improved
by treatment with PSPC. Similarly the present study further
demonstrated that PSPC could attenuate the impairment of
memory and the changes of inﬂammation and aging factors
inD-gal-treatedmice.TheresultssuggestedthatPSPCmight
improve the behavior performance of the mice not only
by increasing the level of the synaptic proteins but also
by enhancing the antioxidant ability which could resume
activity of antioxidant enzymes, attenuate lipid peroxidation
and result in inhibiting inﬂammatory response in mouse
brain.
In conclusion, the present study demonstrated that
PSPC administration attenuated D-gal-induced aging-
related changes in mouse brain. PSPC increased the activity
of Cu/Zn-SOD and CAT, decreased the expression of iNOS
and COX-2, downregulated the expression of GFAP and
MDA content, and inhibited nuclear translocation of NF-κB.
PSPC consequently improved the spontaneous behavior
and cognitive performance and enhanced the capacity of
the brain inherent antioxidant or anti-inﬂammation. These
ﬁndings about the pharmacological eﬃcacy of PSPC would
contribute to brain aging research or aging-related diseases
research.8 Journal of Biomedicine and Biotechnology
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